When metrics are absent, this is what success looks like

“Hi Paul,

“From J, our boss at GT. Thank you for making this excellent content for us! - “S”

“Great story! Thanks for sharing.” - J

Sometimes a few words is all it takes to validate, at least in part, the value of the work and the audience. It’s especially true when the client’s boss goes out of his or her way to do so.

This is the piece that prompted the note. It addresses a core audience of institution researchers, engineers and faculty highlighting end-to-end high value work for an innovative medtech team who has successfully survived the arduous journey from concept to commercialization and is now scaling sales.

It’s really good stuff, especially in its realm and a solid example of a core component of my work. Enjoy.

From Phase Zero to Full On Sales Mode: GCMI Proudly Supports Jackson Medical’s Mission to Eliminate Never Events in the O.R.

“Ultimately, the Jackson Medical team followed the entirety of the GCMI Commercialization Pathway all the way from Phase Zero through design, development, verification, validation and transfer to production.

“[Recent] developments place a bullseye on GloShield as a tool critical to accomplishing the risk of surgical fires and burns per the practice guidelines. GloShield was granted a U.S. patent in April 2023.

“As simply as I can state it, we are currently focused most intently on capitalizing on market opportunities for growth and working with GCMI on two early stage new products complementary to GloShield” Rains says.

“We can’t get where we want to go, as efficiently and effectively as we need to get there without GCMI.”

You can check out the full piece via my contribution to W2M’s efforts on behalf of legacy client GCMI.